4D Molecular Therapeutics FDMT
$ 8.31
-4.15%
Quarterly report 2024-Q3
added 11-13-2024
Country |
USA |
IPO year |
2020 |
Industry |
- |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
- |
Employees in the company |
- |
Shares |
39.1 M |
Market Cap[1] |
$ 325 M |
EBITDA (LTM) |
$ -141 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.